NCTM advises DOC Generici management on acquisition by Charterhouse Capital Partners
NCTM Studio Legale Associato has advised the management of pharmaceutical group DOC Generici — owned by Apotex, Chiesi Farmaceutici and Zambon — on the group’s buyout by private equity fund Charterhouse Capital Partners.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from NCTM
News from The Lawyer
Briefings from NCTM
The available remedies.
No amendment to plan can now be made by debtor after voting.
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms